Profile banner
Sangram Raut, PhD

Sangram Raut, PhD

Clinical research director and translational nanomedicine scientist

srdallas
Fort Worth, Texas
Joined January 2026
Favicon imageclinicalinvestigationsoftexas.com
Favicon imageclinicalinvestigationsoftexas.com
Favicon imagescholar.google.com

Network

2.2K connections
🧪
Clinical Research & Development Professionals
📈
Clinical Drug Development Leaders
🎯
Strategy & Business Development Leaders
⚕️
Life Sciences & Medical Affairs Professionals
🎓
Academic Researchers & Educators
🎗️
Oncology Clinical & Medical Affairs
✍️
Medical & Scientific Writers

Summary

Translational nanomedicine researcher focused on HDL-mimetic drug delivery nih+2
Clinical research leader and entrepreneur running a site-focused clinical research organization clinicalinvestigationsoftexas+1
Experienced academic collaborator with a strong publication record in fluorescence spectroscopy, nanomaterials, and targeted drug carriers google+1
Demonstrated career transition and industry engagement, bridging academic research and clinical development youtube+1

Work

Education

Projects

Writing

A Spontaneous Assembling Lipopeptide Nanoconjugate Transporting the Anthracycline Drug N-Benzyladriamycin-14-valerate for Personalized Therapy of Ewing Sarcoma

February 1, 2024

Describes MYR-5A HDL-mimetic nanotransporters designed to carry lipophilic anthracycline drugs (AD198) selectively to cancer cells via SR-B1, demonstrating enhanced efficacy and reduced cardiotoxicity in preclinical models.

Favicon imagepubmed.ncbi.nlm.nih.gov

Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence

January 1, 2020

Reports on the self-assembly and characterization of a myristic acid-conjugated peptide (MYR-5A) into nanomicellar structures and evaluates their potential as drug carriers targeting SR-B1.

Favicon imagepubmed.ncbi.nlm.nih.gov

Reconstituted HDL: drug delivery platform for overcoming biological barriers to cancer therapy

January 1, 2018

Review/overview of rHDL nanoparticles as a drug delivery platform addressing biological barriers to cancer therapy and leveraging SR-B1 receptor-mediated targeting.

Favicon imagescienceopen.com

Resonance energy transfer between fluorescent BSA protected Au nanoclusters and organic fluorophores

January 1, 2014

Describes methods to enhance brightness of BSA-protected gold nanoclusters via resonance energy transfer to organic dyes, with applications in imaging and biosensing.

Favicon imagepubmed.ncbi.nlm.nih.gov

Similar profiles

MS

Mohammed Salman

Application Specialist at Sedeer Medical

AB

Alex Benjamin

Vice President, Talent Acquisition & FSP Delivery - Pharma, Biotech, CRO at OnPoint Consulting Services

KA

Kartheek A

SM

Shouvik Mondal

Assistant Professor at Netaji Subhas University

KS

Kunal Sampat

Interim Director, Medical Product Development Management at San Jose State University

SB

Saathvik Boompelli

Fellow at Z Fellows